🩺 Now Hiring: Nurse Practitioner · $70/hr · Part-Time · Canton, Baltimore — View the Role & Apply →
Off-Label · Anesthesiologist-Led · Breastfeeding Review Included · Baltimore MD

Ketamine for Postpartum
Depression in Baltimore

When the first weeks of motherhood feel nothing like they were supposed to — you are not alone, and this is treatable

Ketamine for postpartum depression Baltimore costs $499.99 per session ($375 for Vitality Circle members) and is an off-label IV infusion evaluated for PPD that hasn't responded adequately to FDA-approved PPD treatments, SSRIs, or therapy. Postpartum depression affects roughly 10–15% of mothers — about 1 in 7 — and is distinct from the baby blues, which fade within two weeks; persistent symptoms warrant prompt screening. Breastfeeding status is reviewed individually, in coordination with your OB/GYN and pediatrician — no blanket reassurance, no blanket exclusion. Ketamine's NMDA pathway is distinct from the neurosteroid treatments approved for PPD, which is why it is considered when those fall short. Every infusion is delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins anesthesiologist, with a Certified Registered Nurse Anesthetist (CRNA) on-site. Self-pay with an itemized superbill you can file with your insurance; not everyone is a candidate.

5.0·103 Google reviews

"The team is extremely professional, compassionate and knowledgeable — they take the time to explain the process thoroughly and care about your well-being throughout." — Google review, Vita Nova patient

✓ Zuranolone & Brexanolone — FDA-Approved for PPD Ketamine — Off-Label From $375/Session (Members) Breastfeeding Review Included 🌸 Coordinated With Your Care Team Self-Pay · Superbill Provided
Ketamine therapy for postpartum depression at Vita Nova Ketamine and Wellness Clinic, 513 Bayview Blvd Canton Baltimore MD — off-label infusions with breastfeeding review, anesthesiologist-led
Ketamine for postpartum depression — Vita Nova · 513 Bayview Blvd, Canton, Baltimore MD 21224 · Breastfeeding review included · Anesthesiologist-led
BJ
Medically Reviewed By
Dr. Brijen L. Joshi, MD
Reviewed August 2026

Founder & Medical Director, Vita Nova · Johns Hopkins Faculty Physician · Assistant Professor, Anesthesiology & Critical Care Medicine · Chief, Thoracic Anesthesia, Johns Hopkins Hospital · Board-Certified Anesthesiologist

🛡️ LegitScript Certified 🏥 Johns Hopkins
Start Your Evaluation
If FDA-approved PPD treatments or SSRIs haven't provided enough relief, ketamine may be appropriate. A telemedicine consultation is the first step — your provider reviews your full history, including breastfeeding status, and coordinates with your OB/GYN and pediatrician before any recommendation is made.
Book Telemedicine Consultation → View Self-Pay Pricing
LegitScript Certified — Vita Nova Ketamine & Wellness Clinic BusinessRate Best Mental Health Clinic Baltimore 2026 — Vita Nova
🤱 Breastfeeding Review Included
🌸 Coordinated With Your OB/GYN & Pediatrician
🏥 Johns Hopkins Faculty MD
💵 HSA / FSA · Self-Pay · Superbills
🦅 Community Heroes Discounts

Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059

Postpartum Depression & Ketamine at a Glance
1
FDA-approved PPD-specific treatments exist — zuranolone (Zurzuvae, 2023) and brexanolone (Zulresso, 2019). These should be explored first. Ketamine is evaluated when first-line approaches have not produced adequate relief
2
Ketamine is off-label for PPD — not FDA-approved for postpartum depression specifically. Off-label prescribing is a legal, standard medical practice, here anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins faculty anesthesiologist
3
Breastfeeding is reviewed individually — not a blanket contraindication. Compatibility and infusion timing are discussed during the evaluation and coordinated with your OB/GYN and pediatrician, so you do not navigate the decision alone
4
Mechanism: PPD involves neurosteroid withdrawal (progesterone → allopregnanolone drop). Ketamine's NMDA pathway addresses residual mood circuit dysfunction not reached by neurosteroid-targeting treatments
5
Pricing: $499.99/session non-member · $375/session Vitality Circle member (save $124.99). The Complete Series of 6 infusions is $2,250 for members and includes 3 complimentary hydration IVs. Self-pay with an itemized superbill · HSA/FSA accepted
6
PPD affects 1 in 7 new mothers — it is not weakness, not failure, and not permanent. With the right care pathway, recovery is achievable. You deserve support that works
Free · No Commitment · 2 Minutes
Not Ready to Book?
Tell Us About Your Situation

Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.

Your information is confidential. A clinical team member follows up within 1 business day.

01
You Are Not Alone

What Is Postpartum Depression?

"If you're reading this page, you may be months into what was supposed to be one of the most joyful times of your life — and instead you feel absent, exhausted, or afraid of your own thoughts."

That is not weakness. That is not a sign that you are a bad mother. That is postpartum depression — and it is more common, more complex, and more treatable than most new parents are told. Approximately 1 in 7 new mothers develop PPD. It is a medical condition with a biological basis, not a reflection of how much you love your baby or how capable a mother you are. You deserve care that actually works.

Postpartum depression is a major depressive episode occurring during pregnancy or within 4 weeks of delivery — though in practice, symptoms commonly emerge and persist for months following childbirth. It is distinct from the transient "baby blues" in severity, duration, and the degree of functional impairment it causes. In its more severe forms it can include intrusive thoughts, thoughts of self-harm, and suicidal ideation — all of which require prompt clinical attention.

Normal & Transient
Baby Blues
  • Mood swings, tearfulness, irritability
  • Anxiety and overwhelm in the first days
  • Affects up to 80% of new mothers
  • Resolves within 2 weeks without treatment
Baby blues are normal. If symptoms persist beyond 2 weeks or worsen, clinical evaluation is warranted.
Clinical Condition — Requires Treatment
Postpartum Depression
  • Persistent low mood lasting beyond 2 weeks
  • Difficulty bonding with your baby
  • Feelings of worthlessness, guilt, or failure as a mother
  • Loss of interest in activities previously enjoyed
  • Significant anxiety, panic, or intrusive thoughts
  • In severe cases — thoughts of self-harm or suicidal ideation
If you are experiencing thoughts of self-harm, call or text 988 now — or go to your nearest emergency room.
02
First-Line Treatments — Try These Before Ketamine

FDA-Approved PPD Treatments — Start Here

Postpartum depression is the one mental health condition on this site with FDA-approved treatments designed specifically for it. These should be your first clinical conversation — before ketamine is evaluated.

✅
First-Line Options — FDA-Approved & Evidence-Based
The following treatments are either FDA-approved specifically for PPD or are standard evidence-based first-line approaches. Documentation of prior treatment attempts is reviewed during the Vita Nova clinical evaluation.
Zuranolone (Zurzuvae)
FDA-Approved Aug 2023

The first oral medication FDA-approved specifically for PPD. A 14-day neurosteroid treatment that rapidly restores GABA-A receptor tone depleted by postpartum progesterone withdrawal. Available by prescription from your OB/GYN or mental health prescriber.

Brexanolone (Zulresso)
FDA-Approved 2019

IV synthetic allopregnanolone given as a 60-hour continuous inpatient infusion in a certified setting. Directly restores the neurosteroid that drops precipitously after delivery. Requires inpatient monitoring.

SSRIs & Talk Therapy
Standard First-Line

SSRIs (sertraline, escitalopram) are commonly prescribed for PPD with an established evidence base. Interpersonal therapy (IPT) and CBT are first-line psychological approaches with strong PPD-specific evidence.

Ketamine is not a first-line PPD treatment. It is evaluated for patients who have not achieved adequate relief from the above approaches. If you have not yet spoken with your OB/GYN or a perinatal mental-health provider about these options, that is the recommended first step.
03
Why Ketamine May Work for PPD

The Mechanism — Neurosteroid Withdrawal & NMDA Pathways

Understanding why ketamine may be relevant to postpartum depression requires understanding the specific biology of PPD — which is distinct from the biology of standard major depression.

1
The Progesterone Withdrawal Trigger

During pregnancy, progesterone rises dramatically and is converted to allopregnanolone — a neurosteroid that provides powerful inhibitory calming tone through GABA-A receptor modulation. After delivery, progesterone drops precipitously within 24–48 hours. Allopregnanolone falls with it — withdrawing the GABAergic calming effect the brain has adapted to over 9 months. This neurosteroid withdrawal is the primary biological trigger of postpartum depression for most affected women.

2
Why Neurosteroid Treatments Work — And When They Don't

Brexanolone and zuranolone work by directly restoring allopregnanolone levels. For many women, this is highly effective. For others, neurosteroid restoration alone does not fully resolve the depression — because postpartum mood dysregulation involves more than one biological pathway. Chronic sleep deprivation, the metabolic demands of breastfeeding, inflammatory changes, and glutamatergic circuit stress can all contribute to persistent PPD beyond the neurosteroid component.

3
Where Ketamine's NMDA Mechanism Fits

Ketamine targets a different pathway entirely — NMDA glutamate receptor blockade, rapid BDNF release, and synaptogenesis in prefrontal and limbic mood circuits. For patients whose PPD has not responded adequately to neurosteroid treatments or SSRIs, ketamine's glutamatergic mechanism may address the residual mood circuit dysfunction that the neurosteroid-targeting approach did not fully reach.

4
Rapid Onset — Particularly Relevant for New Mothers

The speed of ketamine's antidepressant effect has particular clinical relevance in the postpartum period. A new mother who cannot be present for her baby needs relief as quickly as possible. The weeks required for SSRIs to show effect, or the 14-day zuranolone course, may feel impossibly long. Ketamine's potential to produce meaningful symptom reduction within hours to days is a distinct clinical advantage in this population.

04
Clinical Evidence

The Research Behind Ketamine for PPD

The evidence base for ketamine specifically in postpartum depression is the earliest-stage of any condition evaluated at Vita Nova — based on prevention trials around cesarean delivery, case reports of established PPD, and mechanistic rationale. This is reflected in how the pathway is positioned — as an option for patients who have not responded to established first-line approaches.

Perinatal Trials · Prevention at Delivery
Ketamine Around Cesarean Delivery — What the Trials Show
Most perinatal ketamine research tests a single low dose given during cesarean delivery to prevent PPD, not to treat it once established. A 2022 meta-analysis of those trials found lower rates of depressive symptoms in the first weeks after delivery, and a 2020 double-blind trial of 330 women found a reduction in depressive symptoms at one week. Encouraging for the biology — but this is prevention-at-delivery evidence, and treatment-of-established-PPD data remain limited to case reports.
Li 2022 meta-analysis · PMID 35278826 · Yao 2020 RCT · PMID 32812388
Mechanism Evidence · Neurosteroid Research
Allopregnanolone & GABA-A — The PPD Biology
The neurosteroid basis of PPD is well-established — the approval of brexanolone and zuranolone validates the allopregnanolone withdrawal mechanism clinically. The glutamatergic NMDA system is increasingly recognized as involved in neurosteroid-related mood changes, providing a mechanistic bridge between PPD biology and ketamine's mechanism.
Maguire & Mody — GABA-A neurosteroid plasticity · Deligiannidis — zuranolone trials
Validated in Related Populations
TRD & MDD with Suicidal Ideation Evidence
While PPD-specific ketamine trials are limited, the broader evidence base for ketamine in major depression provides strong mechanistic and clinical support for its use in severe postpartum depression. Many PPD cases that reach ketamine evaluation also meet treatment-resistant depression criteria, where the IV ketamine evidence base is more mature.
Murrough JW et al. (2013). Two-site RCT in TRD · PMID 23982301
Evidence Context — Honest Assessment
Where This Evidence Base Stands
Of all conditions evaluated at Vita Nova, ketamine for PPD has the least mature condition-specific evidence base. The mechanistic rationale is strong and the perinatal prevention trials are encouraging, but no controlled trial has yet tested IV ketamine as a treatment for established PPD. Individual results vary significantly. This is why FDA-approved first-line PPD-specific treatments must be explored first.
Clinical context — Vita Nova Medical Director review, August 2026
05
A Question Many Mothers Ask First

Breastfeeding & Ketamine Therapy

Breastfeeding compatibility is the first question most mothers ask when ketamine is discussed for PPD. The answer is not a simple yes or no — and it is definitely not a blanket "stop breastfeeding." It is an individualized clinical conversation that your Vita Nova provider, your OB/GYN, and your pediatrician have together with you.

🤱
Breastfeeding Compatibility — What We Know & How We Approach It
Breastfeeding compatibility with ketamine therapy is reviewed individually at Vita Nova. It is not a contraindication that automatically excludes you from treatment.
  • ✓

    Ketamine passes into breast milk at low levels. The NIH LactMed database and a 2022 pharmacokinetic study that measured ketamine and its metabolite norketamine in breast milk both describe low milk concentrations that fall within hours as the drug is cleared. These data are small and observational — which is exactly why the decision is individualized rather than assumed.

  • ✓

    Timing-based precautions are used clinically. Many clinicians recommend temporarily withholding breastfeeding for a defined period following each infusion — typically several hours, consistent with ketamine's roughly three-hour half-life — using expressed breast milk during that window.

  • ✓

    Infant exposure data are limited. There are no large controlled studies examining ketamine exposure through breast milk in human infants. This uncertainty is part of the individualized risk-benefit conversation.

  • ✓

    The risk-benefit calculation is yours to make — with support. The decision involves weighing the clinical benefit of effective PPD treatment against theoretical infant exposure during a limited window post-infusion. Neither untreated PPD nor brief ketamine exposure is without consequences.

  • ✓

    Your Vita Nova provider coordinates with your OB/GYN and pediatrician. Breastfeeding timing guidance is discussed in detail during the clinical evaluation and coordinated with your existing care team. You do not have to navigate this decision alone.

06
Cost

Ketamine for PPD — Cost at Vita Nova Baltimore

Ketamine for postpartum depression is off-label. Ketamine at Vita Nova is self-pay — you pay directly, and we provide an itemized superbill you can file with your insurance. HSA and FSA cards are accepted for the full cost, and a member plan brings the per-session rate down. Every infusion is anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins faculty anesthesiologist in a private room with continuous monitoring — that physician-level care is what the per-session price reflects.

TreatmentNon-MemberVitality Circle MemberSaving
Ketamine Infusion — per session Off-Label$499.99$375$124.99/session
Complete Series — 6 infusions · includes 3 complimentary hydration IVs Off-Label$2,849.94$2,250$599.94

Self-pay, with a superbill. Vita Nova is self-pay for ketamine. We provide an itemized superbill you can file with your insurance for possible out-of-network reimbursement. HSA and FSA accepted; Community Heroes discounts available. Pricing August 2026 — subject to change. Full pricing guide →

07
Supportive Wellness

Complementary Treatments Alongside Ketamine for PPD

Pregnancy and the postpartum period deplete vitamin D, iron, B vitamins, and magnesium at rates that significantly affect mood, energy, and neurological function. Always discuss with your OB/GYN before beginning any supplemental therapy postpartum or while breastfeeding.

Important for postpartum patients: These wellness services are general offerings — not treatments for PPD. The appropriate doses and timing must be reviewed by your OB/GYN and pediatrician in the context of your specific breastfeeding situation before beginning supplemental therapy.

08
Community Heroes Program

Special Pricing for Those Who Serve

Postpartum depression does not discriminate by profession — but teachers, nurses, healthcare workers, and military spouses experience PPD under conditions of amplified stress. The Community Heroes program ensures that cost is not a barrier for those who give the most.

🦅 Community Heroes Discount Program · Vita Nova Baltimore
Special Pricing for Those Who Have Served
Postpartum care at Vita Nova is anesthesiologist-led and coordinated with your OB/GYN and pediatrician, with breastfeeding compatibility reviewed individually. Eligibility and specific discount amounts confirmed at booking. Call (443) 563-1059 or submit the Community Heroes form to apply.
🎖️
Veterans & Active-Duty
🚒
Police · Fire · EMS
🚑
EMTs & Paramedics
🏥
Nurses & Healthcare
🍎
Teachers & Educators
🌟
Seniors 65+
09
Frequently Asked Questions

Postpartum Depression & Ketamine — Questions Answered

Common questions from new mothers and their families evaluating ketamine therapy for postpartum depression in Baltimore.

🆘 If you are experiencing thoughts of self-harm or suicidal ideation, call or text 988 (Suicide & Crisis Lifeline) now, or go to your nearest emergency room. For perinatal-specific support, the Postpartum Support International HelpLine is 1-800-944-4773, and the Maternal Mental Health Hotline is 1-833-852-6262.

Ketamine infusions for PPD at Vita Nova cost $499.99 per session for non-members and $375 per session for Vitality Circle members (a member saving of $124.99 per session). The Complete Series of 6 infusions is $2,849.94 for non-members or $2,250 for members and includes 3 complimentary hydration IVs. Ketamine is self-pay; we provide an itemized superbill you can file with your insurance for possible out-of-network reimbursement. HSA and FSA accepted, and Community Heroes discounts are available for veterans, first responders, teachers, nurses, and seniors. See the full pricing guide or verify your benefits (reply in 1–2 business days).
No. IV ketamine for postpartum depression is off-label — not FDA-approved for this specific indication. The treatments FDA-approved specifically for PPD are zuranolone (Zurzuvae, 2023) and brexanolone (Zulresso, 2019), and these — along with SSRIs and therapy — should be explored first. Off-label prescribing is a legal and standard medical practice when a licensed physician determines it clinically appropriate based on the published evidence. At Vita Nova, ketamine for PPD is evaluated only for patients who have not achieved adequate relief from those first-line approaches, and all care is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins faculty anesthesiologist.
Baby blues are a normal, transient experience affecting up to 80% of new mothers in the first 1–2 weeks after delivery — mood swings, tearfulness, and anxiety that resolve without treatment. Postpartum depression is a distinct clinical condition characterized by persistent low mood, inability to bond with the baby, feelings of worthlessness or guilt, loss of interest in activities, anxiety, and in some cases intrusive thoughts or suicidal ideation — lasting beyond 2 weeks and causing significant functional impairment. PPD affects approximately 1 in 7 new mothers and requires clinical assessment and treatment. If your symptoms persist beyond 2 weeks or are worsening, please seek a clinical evaluation promptly.
Yes — and these should be explored before ketamine is evaluated. Zuranolone (Zurzuvae), approved August 2023, is a 14-day oral neurosteroid treatment and the first oral medication FDA-approved specifically for PPD. Brexanolone (Zulresso), approved 2019, is a 60-hour continuous IV infusion of synthetic allopregnanolone given in a certified inpatient setting. Both work by restoring the allopregnanolone neurosteroid tone that drops precipitously after delivery. SSRIs and interpersonal therapy (IPT) are also standard first-line approaches. Ketamine at Vita Nova is evaluated for patients who have not achieved adequate relief from these established approaches.
Breastfeeding compatibility with ketamine therapy is reviewed individually at Vita Nova — it is not a blanket contraindication. The NIH LactMed database and a 2022 breast-milk pharmacokinetic study describe low milk concentrations of ketamine and its metabolite that fall within hours, consistent with ketamine's roughly three-hour half-life — but the data are small and observational, so no blanket reassurance is given. Many clinicians still recommend temporarily withholding breastfeeding for a defined window after each infusion, using expressed milk during that time. This timing guidance is discussed during your clinical evaluation and coordinated with your OB/GYN and pediatrician, who weigh the benefit of effective PPD treatment against theoretical infant exposure with you.
The honest answer is: the evidence is early. Randomized trials of a single low dose given during cesarean delivery — pooled in a 2022 meta-analysis (PMID 35278826) — show fewer depressive symptoms in the weeks after delivery, and case reports describe rapid improvement in established PPD after IV infusions. No controlled trial has yet tested IV ketamine as a treatment for established PPD. The mechanistic rationale is strong — ketamine's NMDA glutamate pathway addresses mood circuit dysfunction complementary to but distinct from the neurosteroid-targeting pathway of brexanolone and zuranolone. Ketamine for PPD is off-label. The condition-specific evidence base is earlier-stage than for treatment-resistant depression or PTSD. Individual results vary significantly. A comprehensive clinical evaluation is required before any recommendation is made.
Based on the broader evidence base for ketamine in major depression, antidepressant effects may appear within hours to days of the first infusion. This rapid onset has particular clinical relevance in the postpartum period — a mother who cannot be present for her baby needs relief as quickly as possible. Individual responses vary, and a full induction series of 4 to 6 infusions is typically used to assess and consolidate response. Ketamine is delivered alongside your existing PPD care, not as a replacement for it.
Sometimes, indirectly. Iron-deficiency anemia is common after childbirth — especially following blood loss at delivery — and it causes fatigue, brain fog, low mood, and poor concentration that overlap with and can worsen postpartum depression. Iron is also a cofactor in the synthesis of dopamine and serotonin. An Iron IV does not treat PPD and is not part of the ketamine protocol — but if bloodwork confirms iron-deficiency anemia, correcting it can lift a physical fatigue layer sitting on top of the depression. Ask your OB/GYN about checking ferritin and a CBC; when deficiency is confirmed, an Iron IV infusion restores stores faster than oral iron, which many new mothers tolerate poorly.
Several wellness services at Vita Nova address nutritional deficits common in the postpartum period. Vitamin D3 shots address severe D3 depletion common in breastfeeding mothers in Baltimore's northern latitude. B12 and B-Complex shots address B-vitamin depletion from pregnancy and breastfeeding. Magnesium shots support NMDA receptor function and nervous system calming relevant to ketamine's mechanism. Iron IV therapy addresses postpartum iron-deficiency anemia — a common contributor to fatigue and mood symptoms. These are general wellness services — not PPD treatments. Always confirm supplemental therapy with your OB/GYN and pediatrician. Vitality Circle members can choose 2 IM shots as their included monthly perk (or 1 standard IV drip, 2 IV pushes, or 1 shot + 1 push) and 25% off Iron IV.
Yes. You stay awake and aware throughout, and you're monitored the whole time. Many mothers describe a relaxed, dream-like state that fades soon after the infusion ends. You'll need someone to drive you home, and our team will talk with you about timing around feeding.
Postpartum Depression · Anesthesiologist-Led · Baltimore MD

You Deserve to Feel
Present for Your Baby —

When FDA-approved PPD treatments or SSRIs haven't been enough, a different mechanism may help. Breastfeeding compatibility is reviewed individually, care is coordinated with your full team, and all treatment is anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD. Self-pay with an itemized superbill you can file with your insurance. No commitment required.

📍 513 Bayview Blvd · Canton, Baltimore MD 21224  ·  🅿️ Free Parking
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM · (443) 563-1059

Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic.  ·  View full team →

Medical Disclaimer: Ketamine infusion therapy for postpartum depression is off-label — not FDA-approved for this specific indication. FDA-approved treatments for postpartum depression include zuranolone (Zurzuvae) and brexanolone (Zulresso) — these should be explored as first-line options before ketamine evaluation. Off-label prescribing is a legal and standard medical practice when determined clinically appropriate by a licensed physician. Breastfeeding compatibility is reviewed individually — this is not a blanket contraindication but requires individualized clinical discussion with your OB/GYN, pediatrician, and Vita Nova provider. Individual eligibility requires a comprehensive clinical evaluation. Individual results vary. This page is for educational purposes only. Please review our Side Effects & Risk Disclosures and Informed Consent pages before scheduling care. If you are experiencing thoughts of self-harm or suicidal ideation, call or text 988 immediately or go to your nearest emergency room. For perinatal-specific support, the Postpartum Support International HelpLine is 1-800-944-4773 and the National Maternal Mental Health Hotline is 1-833-852-6262.